Patients with combined pulmonary fibrosis and emphysema clinical syndrome have an increased risk of complications (pulmonary hypertension, lung cancer and mortality) compared to those with IPF and no emphysema or emphysema less than 10–15%https://bit.ly/4a4viNJ